Chemotherapy News and Research

Latest Chemotherapy News and Research

UC Riverside research team receives NIH grant to study breast cancer

A research team led by biochemists at the University of California, Riverside, has received a four-year grant from the National Institutes of Health, or NIH, to study breast cancer -- the most common cancer in women worldwide -- and the racial disparities in the treatment of the disease.

8 Jan 2020

Study shows potential new approach to treating two common subtypes of lymphoma

A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes of lymphoma through manipulation of molecular programs controlled by the cAMP-response element binding protein.

8 Jan 2020

Children with peripherally inserted central catheters are more likely to develop blood clots, study shows

A study has found that children inserted with PICCs are at higher risk of developing blood clots called venous thromboembolism.

8 Jan 2020

Low intensity pulsed ultrasound selectively targets cancer cells while sparing healthy cells

Doctors have used focused ultrasound to destroy tumors in the body without invasive surgery for some time. However, the therapeutic ultrasound used in clinics today indiscriminately damages cancer and healthy cells alike.

7 Jan 2020

UChicago expert sheds light on pancreatic neuroendocrine tumors

Pancreatic cancer has been in the national spotlight lately with "Jeopardy" host Alex Trebek revealing his diagnosis. For the majority of all pancreatic cancer cases, the cancer begins in the ducts of the pancreas.

7 Jan 2020

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute's capabilities for studying and treating lung cancer.

7 Jan 2020

New brain tumor research could improve patient diagnosis, treatment options

New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000 people in the UK diagnosed with a brain tumour each year.

7 Jan 2020

Using CRISPR to switch off pain gene becomes a possibility with new study

A pathbreaking study reports success in disabling an important gene that is responsible for inducing the sensation of pain.

7 Jan 2020

New antibody-drug conjugate shows promising activity in salivary gland tumors

The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology.

7 Jan 2020

Phase II case-control trial initiated for four types of terminal cancers

The Alexandrov National Cancer Centre begins phase II case-control clinical trial of its immuno-oncology agent, Elenagen.

7 Jan 2020

Radical procedures to treat oral infections are not necessary before stem cell transplantation

A recently published study indicates that oral infections seem to have no association with the risk of stem cell transplantation patients dying of or getting a serious infection within six months of the procedure.

3 Jan 2020

Researchers study new immunogenic properties of already existing anti-cancer drugs

The world scientific community is waging a difficult and prolonged war on cancer. New research in the field of immunogenic cell death can extend the area of drugs application and ensure patients' protection from relapse after therapy.

3 Jan 2020

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.

2 Jan 2020

Researchers move closer to identifying leukemic stem cells

Acute myeloid leukemia is the most common type of leukemia in adults. It is characterized by the pathological expansion of immature cells (myeloblasts) that invade the bone marrow and expand into the blood, affecting the production of the rest of the healthy cells.

2 Jan 2020

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania.

28 Dec 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

UC Riverside research team receives NIH grant to study breast cancer

Study shows potential new approach to treating two common subtypes of lymphoma

Children with peripherally inserted central catheters are more likely to develop blood clots, study shows

Low intensity pulsed ultrasound selectively targets cancer cells while sparing healthy cells

UChicago expert sheds light on pancreatic neuroendocrine tumors

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

New brain tumor research could improve patient diagnosis, treatment options

Using CRISPR to switch off pain gene becomes a possibility with new study

New antibody-drug conjugate shows promising activity in salivary gland tumors

Phase II case-control trial initiated for four types of terminal cancers

Radical procedures to treat oral infections are not necessary before stem cell transplantation

Researchers study new immunogenic properties of already existing anti-cancer drugs

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

Researchers move closer to identifying leukemic stem cells

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

Proton therapy reduces the relative risk of side effects for cancer patients

Lab-grown brain organoids may hold the answers to personalized treatments for glioblastomas

Many stomach cancer patients under 60 have a 'genetically and clinically distinct' disease

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

SLU researcher honored for finding better pain treatments

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in